Pulse Biosciences, Inc. (PLSE) Balance Sheet
As of 2026-06-30 (10-Q), Pulse Biosciences, Inc. (PLSE) reported total assets of $115.6M, total liabilities of $16.1M and shareholders' equity of $99.5M, according to EquiReason's reading of its SEC filings. Cash and equivalents: $101.6M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
PLSEPulse Biosciences, Inc.Follow PLSE — free
—
Price chart with a free account
- Market cap
- 3.8B
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 16 Nov, in 23 days
| Line | FY2016 Dec 16 | FY2017 Dec 17 | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | Latest Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 2.1 | 3.4 | 51.1 | 6.9 | 12.5 | 44.4 | 61.1 | 44.4 | 118.0 | 80.7 | 101.6 | |
| Short-term investments | 14.3 | 34.7 | 8.5 | 18.5 | 8.0 | — | — | — | — | — | — | |
| Receivables | — | — | — | — | — | 0.1 | 0.0 | — | 0.0 | 0.3 | 0.1 | |
| Inventory | — | — | — | — | — | 5.8 | 0.0 | — | 0.0 | 0.1 | 0.2 | |
| Current assets | 16.7 | 38.5 | 60.4 | 26.4 | 22.3 | 45.3 | 62.1 | 45.3 | 119.4 | 83.4 | 105.7 | |
| Total assets | 26.3 | 49.8 | 70.6 | 41.9 | 41.3 | 59.2 | 77.9 | 59.2 | 132.5 | 94.5 | 115.6 | |
| Current liabilities | 1.0 | 2.2 | 3.1 | 4.5 | 7.6 | 6.7 | 6.0 | 6.7 | 10.1 | 7.9 | 11.0 | |
| Long-term debt | — | — | — | — | — | — | 65.0 | 0.0 | — | — | — | |
| Total liabilities | 1.0 | 3.8 | 4.3 | 11.2 | 18.4 | 14.8 | 80.1 | 14.8 | 17.6 | 13.9 | 16.1 | |
| Shareholders' equity | 25.3 | 46.0 | 66.3 | 30.7 | 22.9 | 44.4 | -2.2 | 44.4 | 114.9 | 80.7 | 99.5 |
USD millions · SEC XBRL
Pulse Biosciences, Inc. — questions
- How much cash does Pulse Biosciences, Inc. have?
- $101.6M in cash and cash equivalents as of 2026-06-30.
- What are Pulse Biosciences, Inc.'s total assets?
- $115.6M as of 2026-06-30.
- What is Pulse Biosciences, Inc.'s shareholders' equity?
- $99.5M as of 2026-06-30.
Every figure on this page comes from Pulse Biosciences, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.